|
Setting the Gold Standard for Infectious Disease Diagnostics
With our industry-leading portfolio of proprietary biological and technological diagnostic solutions, we are dedicated to propelling your diagnostic and research endeavours forward.
With one of the most extensive portfolios of infectious disease antigens in the industry, we have the viral, bacterial, and parasitic products to meet your diagnostics needs. Beyond diagnostics, our products are also instrumental in advancing research in fields like epidemiology, virology, and immunology.
Our Quality Assessment Products (QAPs™) are expertly designed to emulate patient samples using native pathogens or synthetic genomes. Trust in our ready-to-use solutions to enhance the precision and reliability of your diagnostic processes.
Our Control Elution Buffer is a sample elution buffer stable for control swab formulations used in diagnostic tests. The product is commonly used as an intermediate step for preparing the control swab formulations in verification/validation protocols including the swab sample elution step. Our DxTM™ is an IVD medical device expertly designed for the secure collection and transport of specimens and only available for sale in Canada.
Microbix offers aseptic custom filling services in a state-of-the-art facility across a range of fields to meet your needs on a pilot, or commercial scale compliantly. The aseptic capabilities include two types of filling lines include 10,000 vials per day, or 60,000 vials per day.
Diagnostic & Research Solutions for the Entire Healthcare Ecosystem
Our large portfolio of infectious disease antigens are produced at commercial scale and serve as key ingredients for manufacturing diagnostic tests and external quality control materials. The antigens can also be used for vaccine R&D, and applied research in virology, microbiology, cell biology, immunology, and pathology.
Covering infections such as Adenovirus, RSV, Parainfluenza 2 & 3, Flu A & B, and Chlamydia pneumoniae for test innovation and development.
ToRCH infections including Toxoplasmosis, Other (Varicella Zoster virus), Syphilis, and Parvovirus B19), Rubella Virus, Cytomegalovirus, and Herpes Simplex Virus.
Specialize in chilchood disease immunological test development for Measeles, Mumps, Rubella, Epstein-Barr Virus, and Varicella Zoster. Dengue panel covering Dengue Types 1, 2, 3, and 4.
Sexually Transmitted Infections covering Chlamydia trachomatis, Herpes Simplex 1 & 2
Respiratory Panel IVD controls and RUO samples are available as single-analyte and multiplex liquid and swab formulations. The panel covers SARS-CoV-2, Flu A & B, RSV, Parainfluenza viruses, Adenovirus, Group A Strep, and more.
Extensive high-risk HPV panel, covering HPV types 16, 18, 31, 33, 39, 45, 51, 52, and 66. HPV IVD Controls and RUO Samples are available as single-analyte and multiplex liquid and swab formulations.
STI and Genital Ulcer Disease IVD Controls and RUO Samples are available as single-analyte and multiplex liquid and swab formulations. The panel covers Chlamydia trachomatis, Neisseria gonnorrhoeae, Trichomonas vaginalis, Mycoplasma genitalium (and antimicrobial resistant strains), HSV1 &2, Varicella Zoster Virus, Treponema pallidum, and Monkeypox virus.
Gastrointestinal IVD Controls and RUO Samples are available as single-analyte and multiplex liquid and swab formulations. The panel includes Cryptosporidium parvum, Giardia lamblia, Helicobacter pylori, C. difficile, Campylobacter, Rotavirus, and more.
Our Featured Infectious Disease Diagnostic Products
These products are whole workflow External Quality Controls that are formulated on Copan FLOQSwabs and inactivated to meet clinical laboratory biosafety requirements. Products are stable at ambient temperature for 2 years.
Formulated with inactivated SARS-CoV-2, Influenza A, Influenza B, and Respiratory Syntactical Virus. Suitable for nucleic acid amplification tests.
Formulated with inactivated native Herpes Simplex 1 & 2, VZV, and cells containing Treponema pallidum genome.
Formulated with inactivated cells and human fibroblast cells from the Sexually Transmitted Infections panel.
Featuring purified native rubella antigen free of detergent. Residual non-viral protein may come from host tissue and culture medium.
CMV Grade 2 for detecting CMV infection in IgG and IgM assays.
Cultured native M. pneunomiae (Strain RH) suitable for immunoassays
Testimonials
Proudly Supporting Over 100+ Customers with Leading Diagnostic Solutions
Learn more about how our clients worldwide use Microbix’s product lines to enhance the way they do business.
We considered other external quality controls but selected Microbix QAPs as the best solution to support assay optimization and to significantly simplify QC procedures with minimal to no pipetting steps. Microbix’s technical expertise, product design, performance, and superior customer service are impressive. We look forward to continuing our collaboration.
Robert Martinez, VP of Business Development & Scientific Affairs
We were looking for a set of controls that fully covered the range of high-risk HPV types and Microbix is the only company to have such a portfolio. After an extensive evaluation process, we concluded the performance of Microbix QAPs are exactly what Ulisse needs and the interactions with their team are delightful.
Bruna Marini, COO
MDx testing for HPV improves cervical cancer screening by identifying those at-risk efficiently. Close monitoring of the entire HPV testing workflow is critical to realizing this healthcare goal and Microbix’s HPV QAPs have been selected to support the quality assessment monitoring of the molecular testing process, a vital part of BVO’s quality management system
Dr. Rob Schuurman, National Reference Officer for the Dutch Cervical Cancer Screening Program (BVO)
r-Biopharm is pleased that the program will be delivering world-class diagnostic testing to some of the most remote populations in Australia. It has been a privilege to work with the program’s operational team and Microbix to integrate the use of the best possible test and test-workflow controls into the program
Andreas Simons, Director, Project Management Clinical Diagnostics
We’re pleased to be employing Microbix’s innovative QAPs for this new and important EQA program. Genital ulcers are the cause of a considerable and growing burden of disease that can only be alleviated by way of accurate diagnosis and treatment
Juha Wahlstedt, Sales Director at Labquality
Microbix approached us before the pandemic started, and the relationship developed so easily and quickly that we formalized our collaboration in 2020. Along with their excellent technical capabilities, they have successfully developed relationships with many diagnostics manufacturers around the world. We are pleased that our FLOQSwabs® are their exclusive choice for their growing line of swab formatted QAPs™.
Gaetano Natale, Chief Commercial Officer.
We’ve been using Microbix’s External Quality controls for 3 years specifically from their Respiratory and Sexually Transmitted Infections panels on our instruments. It has helped us ensure accurate and reliable patient results and we’ve been delighted with their performance.
Alfie Zhen Fang, Buyer, Procurement
Scientific Posters
A Breakthrough for STI Diagnostics
Evaluating the performance of emerging STI point of care assays using novel, room temperature stable CT/NG/TV/MG positive swab quality control materials
Revolutionizing the Detection of Mycoplasma Genitalium
Evaluating the performance of nucleic acid amplification tests that detect mycoplasma genitalium and mutations associated with macrolide resistance using novel quality controls formulated on swabs
Transforming HPV Detection with Advanced Quality Controls
Performance of high-risk HPV single analyte and multiplex panel external quality controla for verification of extended genotyping on the BD Onclarity™ HPV Assay
Resellers Map
Learn more about how our clients worldwide use Microbix’s product lines to enhance the way they do business.
CONTACT US
Let’s discuss how our bio-tech solutions can support your research or diagnostics needs.
+1-800-794-6694